Concord Biotech Limited
NSE: CONCORDBIO.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ankur Vaid
- Employees
- 1,377
- Headquarters
- Ahmedabad, India
- IPO year
- 2023
- Market cap
- ₹122.8B
- Website
- https://www.concordbiotech.com
Loading CONCORDBIO…
Loading profile data…Frequently asked questions about CONCORDBIO
What does Concord Biotech Limited (CONCORDBIO.NS) do?
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. It provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. The company a...
Where does CONCORDBIO.NS trade?
Concord Biotech Limited (CONCORDBIO.NS) trades on the National Stock Exchange of India.
What sector is CONCORDBIO.NS in?
Concord Biotech Limited (CONCORDBIO.NS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Concord Biotech Limited?
Ankur Vaid is the chief executive officer of Concord Biotech Limited (CONCORDBIO.NS).
Where is Concord Biotech Limited headquartered?
Concord Biotech Limited is headquartered in India.
Does CONCORDBIO.NS pay a dividend?
Yes — Concord Biotech Limited (CONCORDBIO.NS) paid a trailing twelve-month dividend of INR 10.70 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CONCORDBIO.NS go public?
Concord Biotech Limited (CONCORDBIO.NS) completed its initial public offering in 2023.